These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34833954)

  • 21. The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk.
    Li L; Cai G; Lu W; Li F; Yu L; Xiao J
    BMC Cardiovasc Disord; 2021 Oct; 21(1):504. PubMed ID: 34666674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects.
    Gille A; Easton R; D'Andrea D; Wright SD; Shear CL
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2106-14. PubMed ID: 24969776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and functional basis for increased HDL-cholesterol levels due to the naturally occurring V19L mutation in human apolipoprotein A-I.
    Gkolfinopoulou C; Bourtsala A; Chroni A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Mar; 1865(3):158593. PubMed ID: 31863971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
    Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
    Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.
    Reyes-Soffer G; Millar JS; Ngai C; Jumes P; Coromilas E; Asztalos B; Johnson-Levonas AO; Wagner JA; Donovan DS; Karmally W; Ramakrishnan R; Holleran S; Thomas T; Dunbar RL; deGoma EM; Rafeek H; Baer AL; Liu Y; Lassman ME; Gutstein DE; Rader DJ; Ginsberg HN
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):994-1002. PubMed ID: 26966279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration.
    Monette JS; Hutchins PM; Ronsein GE; Wimberger J; Irwin AD; Tang C; Sara JD; Shao B; Vaisar T; Lerman A; Heinecke JW
    Circ Res; 2016 Jun; 119(1):83-90. PubMed ID: 27114438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.
    Wu TT; Zheng YY; Yang YN; Li XM; Ma YT; Xie X
    Metab Syndr Relat Disord; 2019 May; 17(4):223-231. PubMed ID: 30720383
    [No Abstract]   [Full Text] [Related]  

  • 28. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease.
    Asztalos BF; Roheim PS; Milani RL; Lefevre M; McNamara JR; Horvath KV; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2670-6. PubMed ID: 11116070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations.
    Ginsberg HN; Ngai C; Wang XJ; Ramakrishnan R
    Arterioscler Thromb; 1993 Jun; 13(6):842-51. PubMed ID: 8499404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice.
    Weinstock PH; Bisgaier CL; Hayek T; Aalto-Setala K; Sehayek E; Wu L; Sheiffele P; Merkel M; Essenburg AD; Breslow JL
    J Lipid Res; 1997 Sep; 38(9):1782-94. PubMed ID: 9323588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects.
    Tilly-Kiesi M; Lichtenstein AH; Joven J; Vilella E; Cheung MC; Carrasco WV; Ordovas JM; Dolnikowski G; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3513-8. PubMed ID: 9437200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.
    Agarwala AP; Rodrigues A; Risman M; McCoy M; Trindade K; Qu L; Cuchel M; Billheimer J; Rader DJ
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1515-9. PubMed ID: 25838421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles.
    Liu L; Bortnick AE; Nickel M; Dhanasekaran P; Subbaiah PV; Lund-Katz S; Rothblat GH; Phillips MC
    J Biol Chem; 2003 Oct; 278(44):42976-84. PubMed ID: 12928428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.
    Mott S; Yu L; Marcil M; Boucher B; Rondeau C; Genest J
    Atherosclerosis; 2000 Oct; 152(2):457-68. PubMed ID: 10998475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent peroxisome proliferator-activated receptor-α agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome.
    Khera AV; Millar JS; Ruotolo G; Wang MD; Rader DJ
    Eur Heart J; 2015 Nov; 36(43):3020-2. PubMed ID: 26112886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo.
    Bailey D; Jahagirdar R; Gordon A; Hafiane A; Campbell S; Chatur S; Wagner GS; Hansen HC; Chiacchia FS; Johansson J; Krimbou L; Wong NC; Genest J
    J Am Coll Cardiol; 2010 Jun; 55(23):2580-9. PubMed ID: 20513599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between fractional esterification rate of high density lipoprotein cholesterol and coronary artery disease].
    Mao W; Dong J; Li HX; Zhou M; Guo HB; Wang S; Chen WX; He Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 May; 39(5):402-5. PubMed ID: 21781592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy.
    Boyer M; Lévesque V; Poirier P; Marette A; Mitchell PL; Mora S; Mathieu P; Després JP; Larose É; Arsenault BJ
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
    Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients.
    Kempen HJ; Asztalos BF; Moerland M; Jeyarajah E; Otvos J; Kallend DG; Bellibas SE; Wijngaard PL
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):736-42. PubMed ID: 26916733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.